Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Chlorin e6-EGF conjugated gold nanoparticles as a nanomedicine based therapeutic agent for triple negative breast cancer

Full text
Author(s):
Castilho, Maiara L. [1, 2] ; Jesus, Viviane P. S. [1] ; Vieira, Paula F. A. [1] ; Hewitt, Kevin C. [3] ; Raniero, L. [1]
Total Authors: 5
Affiliation:
[1] Univ Vale Paraiba, Inst Pesquisa & Desenvolvimento, Lab Nanossensores, UNIVAP, Av Shishima Hifumi 2911, BR-12244000 Sao Jose Dos Campos, SP - Brazil
[2] Univ Vale Paraiba, Inst Pesquisa & Desenvolvimento, Lab Bionanotecnol, UNIVAP, Av Shishima Hifumi 2911, BR-12244000 Sao Jose Dos Campos, SP - Brazil
[3] Dalhousie Univ, Dept Phys & Atmospher Sci, 6310 Coburg Rd, Halifax, NS B3H 4R2 - Canada
Total Affiliations: 3
Document type: Journal article
Source: Photodiagnosis and Photodynamic Therapy; v. 33, MAR 2021.
Web of Science Citations: 0
Abstract

To develop a treatment modality for triple-negative breast cancer, we investigated the efficacy of a bifunctional theranostic nanoprobes (BN) during Photodynamic Therapy (PDT) on human breast carcinoma and normal human cells. The BN is a 21 nm gold nanoparticles functionalized with Chlorin e6 (Ce6) and Epidermal Growth Factor (EGF). Attachment to gold nanoparticle stabilizes Ce6 while EGF acts as a cancer cell targeting agent. Fluorescence Spectroscopy and Confocal Fluorescence Microscopy revealed a gradual uptake of nanoprobes into cancer cells at an average rate of 63 BN/min. Cell viability assays showed that 0.2 ?g/mL BN concentration was highly cytotoxic to cancer cells (86 %), but not normal cells. At this concentration, 58 % cancer cells were necrotic and 38 % apoptotic, while the reactive oxygen species (ROS) was 9-fold higher in cancer cells compared to normal. Overall, results suggest that BN mediated PDT can achieve targeted cancer cell death with high efficiency. (AU)

FAPESP's process: 17/07519-2 - TREATMENT OF BREAST CANCER IN ANIMAL MODEL VIA PHOTODYNAMIC THERAPY ASSOCIATED WITH BIFUNCTIONAL NANOprobes
Grantee:Leandro José Raniero
Support Opportunities: Regular Research Grants